BACKGROUND: Outcomes related to prophylactic catheter ablation (PCA) for ventricular tachycardia (VT) before implantable cardioverter-defibrillator (ICD) implantation in non-ischemic cardiomyopathy (NICM) are not well characterized. We assessed the efficacy of single endocardial PCA in NICM patients. METHODS: We retrospectively analyzed 101 consecutive NICM patients with sustained VT. We compared clinical outcomes of patients who underwent PCA (ABL group) with those who did not (No ABL group). Successful PCA was defined as no inducible clinical VT. We also compared the clinical outcomes of patients with successful PCA (PCA success group) with those of the No ABL group. Endpoints were appropriate ICD therapy (shock and anti-tachycardia pacing) and the occurrence of electrical storm (ES). RESULTS: PCA was performed in 42 patients, and it succeeded in 20. The time to ES occurrence was significantly longer in the ABL group than in the No ABL group (p=0.04). The time to first appropriate ICD therapy and ES occurrence were significantly longer in the PCA success group than in the No ABL group (p=0.02 and p<0.01, respectively). CONCLUSION: Single endocardial PCA can decrease ES occurrence in NICM patients. However, high rates of VT recurrence and low success rates are issues to be resolved; therefore, the efficacy of single endocardial PCA is currently limited.
BACKGROUND: Outcomes related to prophylactic catheter ablation (PCA) for ventricular tachycardia (VT) before implantable cardioverter-defibrillator (ICD) implantation in non-ischemic cardiomyopathy (NICM) are not well characterized. We assessed the efficacy of single endocardial PCA in NICM patients. METHODS: We retrospectively analyzed 101 consecutive NICM patients with sustained VT. We compared clinical outcomes of patients who underwent PCA (ABL group) with those who did not (No ABL group). Successful PCA was defined as no inducible clinical VT. We also compared the clinical outcomes of patients with successful PCA (PCA success group) with those of the No ABL group. Endpoints were appropriate ICD therapy (shock and anti-tachycardia pacing) and the occurrence of electrical storm (ES). RESULTS: PCA was performed in 42 patients, and it succeeded in 20. The time to ES occurrence was significantly longer in the ABL group than in the No ABL group (p=0.04). The time to first appropriate ICD therapy and ES occurrence were significantly longer in the PCA success group than in the No ABL group (p=0.02 and p<0.01, respectively). CONCLUSION: Single endocardial PCA can decrease ES occurrence in NICM patients. However, high rates of VT recurrence and low success rates are issues to be resolved; therefore, the efficacy of single endocardial PCA is currently limited.
Authors: Rupa Bala; Jian-Fang Ren; Mathew D Hutchinson; Benoit Desjardins; Cory Tschabrunn; Edward P Gerstenfeld; Rajat Deo; Sanjay Dixit; Fermin C Garcia; Joshua Cooper; David Lin; Michael P Riley; Wendy S Tzou; Ralph Verdino; Andrew E Epstein; David J Callans; Francis E Marchlinski Journal: Circ Arrhythm Electrophysiol Date: 2011-08-31
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: K Soejima; M Suzuki; W H Maisel; C B Brunckhorst; E Delacretaz; L Blier; S Tung; H Khan; W G Stevenson Journal: Circulation Date: 2001-08-07 Impact factor: 29.690
Authors: Marketa Kozeluhova; Petr Peichl; Robert Cihak; Dan Wichterle; Vlastimil Vancura; Jan Bytesnik; Josef Kautzner Journal: Europace Date: 2010-10-14 Impact factor: 5.214
Authors: Arash Arya; Kerstin Bode; Christopher Piorkowski; Andreas Bollmann; Philipp Sommer; Thomas Gaspar; Ulrike Wetzel; Daniela Husser; Hans Kottkamp; Gerhard Hindricks Journal: Pacing Clin Electrophysiol Date: 2010-12 Impact factor: 1.976
Authors: Frank M Bogun; Benoit Desjardins; Eric Good; Sanjaya Gupta; Thomas Crawford; Hakan Oral; Matthew Ebinger; Frank Pelosi; Aman Chugh; Krit Jongnarangsin; Fred Morady Journal: J Am Coll Cardiol Date: 2009-03-31 Impact factor: 24.094
Authors: E Ene; P Halbfaß; K Nentwich; K Sonne; M Roos; S Fodor; L Lehmkuhl; F Gietzen; S Barth; K Hamm; T Deneke Journal: Herzschrittmacherther Elektrophysiol Date: 2017-05-09